首頁 › 肝癌（肝細胞癌） › 德克薩斯州 › Dallas
Dallas, TX 的 肝癌（肝細胞癌） 臨床試驗
19 項針對 肝癌（肝細胞癌） 的研究正在 Dallas（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
招募中1 期
- Exelixis Clinical Site #89, Dallas
National Liver Cancer Screening Trial
招募中4 期
- UT Southwestern Medical Center and Parkland Hospital, Dallas
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
招募中1/2 期
- University of Texas Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
招募中早期第 1 期
- University of Texas Southwestern Medical Center, Dallas
Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
招募中2 期
- University of Texas Southwestern Medical Center, Dallas
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
招募中1/2 期
- Texas Oncology, P.A., Dallas
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
招募中2 期
- Baylor Scott & White Research Institute, Dallas
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
招募中1 期
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- UT Southwestern Medical Center - Redbird, Dallas
- Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
- 還有 2 項
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
招募中
- University of Texas Southwestern Medical Center, Dallas
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
招募中1 期
- Clinical Trial Site, Dallas
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
招募中
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
招募中1/2 期
- Harold C. Simmons Comprehensive Cancer Center, Dallas
Evaluation of Resection Techniques for Pancreatic Tumors
招募中觀察性研究
- Methodist Dallas Medical Center, Dallas
Ligufalimab and Cadonilimab in Advanced Liver Cancers
招募中2 期
- University of Texas Southwestern Medical Center, Dallas
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
招募中4 期
- UT Southwestern Medical Center, Dallas
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Research Site 120, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Dallas
EGCG for Hepatocellular Carcinoma Chemoprevention
招募中2 期
- UT Southwestern, Dallas
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
招募中3 期
- Site 881, Dallas
其他城市的 肝癌（肝細胞癌） 試驗
- Houston, TX31 項研究
- New York City, NY24 項研究
- Los Angeles, CA19 項研究
- Boston, MA18 項研究
- Cleveland, OH18 項研究
- Chicago, IL16 項研究
- Philadelphia, PA16 項研究
- Pittsburgh, PA15 項研究
- San Francisco, CA14 項研究
- Orange, CA14 項研究
- Jacksonville, FL14 項研究
- San Antonio, TX13 項研究
Dallas 的其他研究
- 乳癌55 項研究
- 非小細胞肺癌52 項研究
- 轉移性癌症42 項研究
- 心臟衰竭42 項研究
- 癌症（所有類型）37 項研究
- 前列腺癌36 項研究
- 大腸直腸癌33 項研究
- 肥胖症30 項研究
- 卵巢癌28 項研究
- 肺癌27 項研究
- 膀胱癌27 項研究
- 子宮內膜癌24 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。